logo

Evogene Ltd. (EVGN)



Trade EVGN now with
  Date
  Headline
1/18/2022 7:05:36 AM Canonic Unveils Positive Results In Pre-Clinical Studies In Its Precise Product Program For Medical Cannabis
1/11/2022 7:08:17 AM Biomica : Israel Clears First-in-Human Phase I Study Of BMC-128 In Combination With Bristol Myers' Anti-PD-1 Opdivo
12/14/2021 7:08:14 AM Lavie Bio Announces Advancement In Its Bio-Fungicide Program For Fruit Rots
11/30/2021 7:02:38 AM Biomica Announces Positive Results From Pre-Clinical Studies In Inflammatory Bowel Disease Program
11/17/2021 7:17:33 AM Evogene Q3 Net Loss $8.3 Mln Vs. Net Loss Of $5.4 Mln Prior Year
11/17/2021 7:12:00 AM Evogene Reports Third Quarter 2021 Financial Results (Press Release)
10/27/2021 8:17:14 AM Biomica & Rambam Health Care Campus Sign Deal For Clinical Trial Of Biomica's Microbiome-Based Immuno-Oncology Drug
8/31/2021 7:04:13 AM Canonic Announces Pre-Launch Of First Generation Medical Cannabis Products In Israel
8/11/2021 7:05:30 AM Evogene Q2 Net Loss Widens To $6.9 Mln From $4.8 Mln Prior Year
8/11/2021 7:00:00 AM Evogene Reports Second Quarter 2021 Financial Results (Press Release)
7/6/2021 7:38:33 AM AgPlenus Reports Positive Results In Proof Of Concept Testing Of Resistance Trait For APH1
6/23/2021 7:13:49 AM Evogene To Appoint Sarit Firon To Serve As Chairperson; Chairperson Martin Gerstel Not Standing For Re-election
5/26/2021 8:00:09 AM Evogene Q1 Loss Per Share $0.17 Vs Loss $0.24 Last Year
5/26/2021 7:55:00 AM Evogene Reports First Quarter 2021 Financial Results (Press Release)
5/25/2021 7:06:55 AM Lavie Bio Appoints Russ Putland As VP Commercial
4/13/2021 7:10:52 AM Biomica Announces Positive Pre-Clinical Results, Demonstrating Efficacy Of BMC128 In Melanoma